harmaline
Sign in to saveHarmaline, also known as 7-methoxyharmalan or as 3,4-dihydro-7-methoxy-1-methyl-β-carboline, is a harmala alkaloid and β-carboline which has hallucinogenic effects and monoamine oxidase inhibitor (MAOI) activity. It is the partly hydrogenated form of harmine.
Article
20 sectionsContents
- Use and effects
- As a hallucinogen
- As an MAOI
- Interactions
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Chemistry
- Properties
- Synthesis
- Analogues
- Natural occurrence
- History
- Society and culture
- Legal status
- Australia
- Canada
- See also
- References
- External links
Harmaline, also known as 7-methoxyharmalan or as 3,4-dihydro-7-methoxy-1-methyl-β-carboline, is a harmala alkaloid and β-carboline which has hallucinogenic effects and monoamine oxidase inhibitor (MAOI) activity. It is the partly hydrogenated form of harmine.
Plants containing harmaline are combined in ayahuasca to inhibit monoamine oxidase, allowing orally consumed dimethyltryptamine (DMT) to become orally active and produce psychoactive effects. Harmala alkaloids, including harmaline, are psychoactive on their own in humans, with harmaline being particularly hallucinogenic, although other compounds such as harmine and tetrahydroharmine have also been reported to produce hallucinogenic effects as well.
Gallery (2)
Connections
Categories
Acetylcholinesterase inhibitorsAntidepressantsBeta-CarbolinesChemical pages without DrugBank identifierDrugs not assigned an ATC codeECHA InfoCard ID from WikidataEntheogensMonoamine oxidase inhibitorsN-MonoalkyltryptaminesOneirogensPhenol ethersPsychedelic-assisted therapyReversible inhibitors of MAO-A